HOPKINTON, Mass., Oct. 13 /PRNewswire/ -- Facet Solutions, Inc. today announced the completion of 6 month follow-up on 20 patients from its US IDE Pilot Study. The results show a 78% reduction in Oswestry Disability Index (ODI) scores, and an 80% reduction in Visual Analog Scores (VAS) for symptomatic leg pain. Geoff Pardo, President & CEO for Facet Solutions, added, "We are very pleased with these early results, which thus far not only demonstrate significant pain relief but the safety of an anatomic and unconstrained design."
Dr. John Regan, of St. Johns Hospital in Santa Monica, CA, will be presenting the results from Facet Solutions' US Pilot Study at 11:17am on Tuesday, October 14th at the NASS Pre-Meeting Course in Toronto, Ontario.
Facet Solutions, Inc. has developed the ACADIA(TM) Facet Replacement System (AFRS(TM)) to provide patients with lumbar spinal stenosis and facet degeneration a motion preserving alternative to lumbar spinal fusion. The ACADIA(TM) procedure includes replacement of the diseased facet joint with an anatomic implant that is designed to restore the natural motion, stability, and balance to the lumbar spine.
*Note: ACADIA(TM) is an investigational device in the United States. It is limited by United States (U.S.) Federal Law for investigational use only.
About Facet Solutions
Facet Solutions, Inc. is a privately held, venture-backed company focused on development and commercialization of surgical devices for the treatment of facet-related spinal disorders. Facet Solutions has received venture capital from its partners De Novo Ventures, Pequot Ventures, and Spray Venture Partners. Facet Solutions is certified to ISO 13485. The company will be attending the upcoming North American Spine Surgeons Meeting in Toronto, Ontario (booth #1406).
CONTACT: Mr. Geoff Pardo, President & CEO of Facet Solutions, Inc.,